These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 25761670)
1. Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation. Lee J; Youn BU; Kim K; Kim JH; Lee DH; Seong S; Kim I; Han SH; Che X; Choi JY; Park YW; Kook H; Kim KK; Lim DS; Kim N J Bone Miner Res; 2015 Sep; 30(9):1597-607. PubMed ID: 25761670 [TBL] [Abstract][Full Text] [Related]
2. Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis. Wu Y; Yang M; Fan J; Peng Y; Deng L; Ding Y; Yang R; Zhou J; Miao D; Fu Q Cell Death Dis; 2014 Oct; 5(10):e1464. PubMed ID: 25321471 [TBL] [Abstract][Full Text] [Related]
3. TRIM38 regulates NF-κB activation through TAB2 degradation in osteoclast and osteoblast differentiation. Kim K; Kim JH; Kim I; Seong S; Kim N Bone; 2018 Aug; 113():17-28. PubMed ID: 29753717 [TBL] [Abstract][Full Text] [Related]
4. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. Yamashita T; Yao Z; Li F; Zhang Q; Badell IR; Schwarz EM; Takeshita S; Wagner EF; Noda M; Matsuo K; Xing L; Boyce BF J Biol Chem; 2007 Jun; 282(25):18245-18253. PubMed ID: 17485464 [TBL] [Abstract][Full Text] [Related]
5. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation. Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436 [TBL] [Abstract][Full Text] [Related]
6. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo. Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094 [TBL] [Abstract][Full Text] [Related]
7. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development. Mukherjee A; Rotwein P Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480 [TBL] [Abstract][Full Text] [Related]
8. Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms. Zeng R; Faccio R; Novack DV J Bone Miner Res; 2015 Dec; 30(12):2287-99. PubMed ID: 26094846 [TBL] [Abstract][Full Text] [Related]
9. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Hikata T; Takaishi H; Takito J; Hakozaki A; Furukawa M; Uchikawa S; Kimura T; Okada Y; Matsumoto M; Yoshimura A; Nishimura R; Reddy SV; Asahara H; Toyama Y Blood; 2009 Mar; 113(10):2202-12. PubMed ID: 18952894 [TBL] [Abstract][Full Text] [Related]
10. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice. Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791 [TBL] [Abstract][Full Text] [Related]
11. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation. Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445 [TBL] [Abstract][Full Text] [Related]
12. Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association. Martin A; Xiong J; Koromila T; Ji JS; Chang S; Song YS; Miller JL; Han CY; Kostenuik P; Krum SA; Chimge NO; Gabet Y; Frenkel B Bone; 2015 Jun; 75():96-104. PubMed ID: 25701138 [TBL] [Abstract][Full Text] [Related]
13. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo. Liu FL; Chen CL; Lai CC; Lee CC; Chang DM Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293 [TBL] [Abstract][Full Text] [Related]
14. Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway. Kim K; Kim JH; Kim I; Seong S; Kim N Mol Cells; 2020 Jan; 43(1):34-47. PubMed ID: 31896234 [TBL] [Abstract][Full Text] [Related]
15. The emerging role of Hippo signaling pathway in regulating osteoclast formation. Yang W; Han W; Qin A; Wang Z; Xu J; Qian Y J Cell Physiol; 2018 Jun; 233(6):4606-4617. PubMed ID: 29219182 [TBL] [Abstract][Full Text] [Related]
16. Leonurus sibiricus L. ethanol extract promotes osteoblast differentiation and inhibits osteoclast formation. Kim JH; Kim M; Jung HS; Sohn Y Int J Mol Med; 2019 Sep; 44(3):913-926. PubMed ID: 31524244 [TBL] [Abstract][Full Text] [Related]
17. The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation. Kim I; Kim JH; Kim K; Seong S; Kim N BMB Rep; 2019 Jul; 52(7):469-474. PubMed ID: 31186082 [TBL] [Abstract][Full Text] [Related]
19. Histone demethylase KDM7A regulates bone homeostasis through balancing osteoblast and osteoclast differentiation. Shan L; Yang X; Liao X; Yang Z; Zhou J; Li X; Wang B Cell Death Dis; 2024 Feb; 15(2):136. PubMed ID: 38346941 [TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms of osteoblast and osteoclast differentiation. Katagiri T; Takahashi N Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]